Library — CHDR

Search

Filter

Lectin and alternative complement pathway activation in cutaneous manifestations of IgA-vasculitis: A new target for therapy?

Damman J, Mooyaart AL, Bosch TPPVD, Seelen MA, Doorn MBV

Molecular immunology, 2022 Mar

View publication
The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder

Francis M Dijkstra, Aurora JAE van de Loo, Smedra Abdulahad, Else R Bosma, Mitch Hartog, Hendrikje Huls, Dianne C Kuijper, Esther de Vries, Bhavna Solanki, Jaskaran Singh, Leah Aluisio, Peter Zannikos, Frederik E Stuurman, Gabriël E Jacobs, Joris C Verster

Journal of Psychopharmacology, 2022 Feb

View publication
Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients.

Moss LM, Algera MH, Dobbins R, Gray F, Strafford S, Heath A, van Velzen M, Heuberger JAAC, Niesters M, Olofsen E, Laffont CM, Dahan A, Groeneveld GJ

PloS one, 2022 Feb; 17(1):e0256752

View publication
Healthy volunteers in first-in-human oncology drug development for small molecules.

de Las Heras B, Bouyoucef-Cherchalli D, Reeve L, Reichl A, Mandarino D, Flach S, Vidal L, van Brummelen EMJ, Steeghs N

British journal of clinical pharmacology, 2022 Feb; 88(4):1773-1784

View publication
De-risking Clinical Trials: The BIAL Phase I Trial in Foresight.

Cohen AF, van Smeden J, Webb DJ

Clinical pharmacology and therapeutics, 2022 Feb; 111(2):362-365

View publication
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005.

Saghari M, Gal P, Gilbert S, Yateman M, Porter-Brown B, Brennan N, Quaratino S, Wilson R, Grievink HW, Klaassen ES, Bergmann KR, Burggraaf J, van Doorn MBA, Powell J, Moerland M, Rissmann R

Clinical pharmacology and therapeutics, 2022 Jan

View publication
Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double-blind, placebo-controlled, cross-over study.

Ruijs TQ, Heuberger JAAC, de Goede AA, Ziagkos D, Otto ME, Doll RJ, van Putten MJAM, Groeneveld GJ

British journal of clinical pharmacology, 2022 Jan

View publication
Simultaneous measurement of intra-epidermal electric detection thresholds and evoked potentials for observation of nociceptive processing following sleep deprivation

Boudewijn van den Berg, Hemme J. Hijma, Ingrid Koopmans, Robert J. Doll, Rob G. J. A. Zuiker, Geert Jan Groeneveld & Jan R. Buitenweg

Experimental Brain Research , 2022 Jan

View publication
Observing Altered Nociceptive Detection Thresholds in Patients With Persistent Spinal Pain Syndrome Type 2 With a Dorsal Root Ganglion Stimulator

Tom Berfelo, Robert-Jan Doll, Imre Poldino Krabbenbos, Jan Reinoud Buitenweg

Neuromodulation: Technology at the Neural Interface, 2022 Jan

View publication

«
1
2
...
11
12
13
14
15
16
17
...
98
99
»